Stephen Nishimura, MD

Pulmonary pathologist

Dr. Stephen L. Nishimura is an expert in pulmonary pathology with an emphasis on interstitial lung disease (ILD) and lung cancer. In his research, Nishimura is investigating the regulation of cell behavior related to development, cell signaling, tumor growth, metastasis, the formation and differentiation of blood vessels and wound repair, particularly in the lungs. Nishimura earned his medical degree from the University of Vermont College of Medicine. He then completed fellowships in anatomic pathology and laboratory medicine, as well as molecular and cell biology at UCSF. Nishimura also completed a fellowship in pulmonary pathology at the Armed Forces Institute of Pathology in Washington, D.C.

Nishimura is the recipient of numerous honors and awards including the American Lung Association, UCSF Academic Senate and American Cancer Society. He is a member of the American Society for Cell Biology and the American Society of Investigative Pathology. Currently, he holds the position of professor in residence in the department of pathology at UCSF.

Academic Title

Professor

More about Stephen Nishimura

Education

University of Vermont College of Medicine 1988

Residencies

UCSF Medical Center, Anatomic Pathology 1991

Selected Research and Publications

  1. Publicover J, Gaggar A, Jespersen JM, Halac U, Johnson AJ, Goodsell A, Avanesyan L, Nishimura SL, Holdorf M, Mansfield KG, Judge JB, Koshti A, Croft M, Wakil AE, Rosenthal P, Pai E, Cooper S, Baron JL. An OX40/OX40L interaction directs successful immunity to hepatitis B virus. Sci Transl Med. 2018 Mar 21; 10(433).
  2. Gotts JE, Chun LF, Abbott J, Fang X, Takasaki N, Nishimura SL, Springer ML, Schick SF, Calfee CS, Matthay MA. Cigarette smoke exposure worsens acute lung injury in antibiotic-treated bacterial pneumonia in mice. Am J Physiol Lung Cell Mol Physiol. 2018 Mar 15.
  3. Stockis J, Liénart S, Colau D, Collignon A, Nishimura SL, Sheppard D, Coulie PG, Lucas S. Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin aVß8. Proc Natl Acad Sci U S A. 2017 Nov 21; 114(47):E10161-E10168.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.